Final ID:
GLP-1RAs and Beyond: Incretin Analogues and a New Frontier in Cardiovascular Therapeutics
Sunday, 11/17/2024 , 09:45AM - 11:00AM
Main Event
Powell-wiley Tiffany, Essien Utibe
How do we SELECT incretin analogues and SUSTAIN their impact? Clinical approaches for short and long-term obesity careJastreboff Ania, Lingvay Ildiko
Nauck Michael, Drucker Daniel, Pratley Richard
Once Weekly Utreglutide (GL0034), a Glucagon-like Peptide-1 Receptor Agonist, at 4 × 450 µg Doses Reduces Blood Pressure, Lipids, and Body Weight in Post-menopausal Females: A Phase I StudyThennati Rajamannar, Vilsboll Tina, Burade Vinod, Natarajan Muthukumaran, Shahi Pradeep, Nagaraja Ravishankara, Agrawal Sudeep, Duvauchelle Thierry, Pratley Richard, Thorens Bernard